Resistance Exercise in Patients With Ocular Melanoma
Recruiting · NCT06970236 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Valencia
View the official record on ClinicalTrials.gov →Interventions studied
Exercise
What this trial is about
Choroidal melanoma (CM) is one of the most common intraocular cancers worldwide. During treatment with episcleral brachytherapy, patients require a week of hospitalization in isolation. The primary aim of this study will be to investigate the effects of resistance training during hospitalization on health-related blood biomarkers in CM patients. Our secondary aim will be to assess changes in physical function tests, quality of life and anxiety and depression. Candidates for this study will be patients undergoing CM treatment at the "Hospital Universitari i Politècnic La Fe" of Valencia.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults with Choroidal Melanoma diagnose and treated with plaque brachytherapy undergoing in "Hospital Universitari i Politècnic La Fe" (Valencia).
Exclusion criteria
- Present a health status that forbids high intensity resistance training.
- Have any unsteady cardiac illness.
- Have serious metabolic disorder.
- Have any important orthopaedic disorder impeding exercise.
Where it is running
1 location listed.
- Hospital Universitari i Politècnic de La Fe - Valencia, Spain, Spain